Skip to Main Content
Bora Acquires Pyros Pharmaceuticals to Bolster Upsher-Smith Rare Disease Product Portfolio
Open to Strategic Partnerships and Product Collaborations

Corporate Development

Upsher-Smith is proud of its heritage as a trusted name in pharmaceuticals.

We are specifically interested in opportunities to acquire, license or co-develop:

  • Diverse dosage forms of generic products across all indications
  • Niche generic products for orphan indications which could benefit from Upsher-Smith’s unique promotional strategies and specialty-pharmacy partnerships
  • Key focus on late-stage generic assets with launch potential within the next 2 years
  • Potential technical transfer opportunities for oral dosage forms to leverage our new state-of-the-art manufacturing facility

Together, we seek to deliver the best value for our mutual stakeholders, and most importantly, to Do More Good™ for the patients we serve.

Contact us at USLinfo@upsher-smith.com.

Careers

Join Our Team!

We’re hiring

Search Our Jobs

Close